191 related articles for article (PubMed ID: 31571158)
21. Impact of the Extent of Lymph Node Dissection on Precise Staging and Survival in Clinical I-II Pure-Solid Lung Cancer Undergoing Lobectomy.
Chen D; Mao Y; Wen J; Shu J; Ye F; She Y; Ding Q; Shi L; Xue T; Fan M; Chen Y; Chen C
J Natl Compr Canc Netw; 2021 Apr; 19(4):393-402. PubMed ID: 33508774
[TBL] [Abstract][Full Text] [Related]
22. Impact of examined lymph node number on lymph node status and prognosis in FIGO stage IB-IIA cervical squamous cell carcinoma: A population-based study.
Yong J; Ding B; Dong Y; Yang M
Front Oncol; 2022; 12():994105. PubMed ID: 36203444
[TBL] [Abstract][Full Text] [Related]
23. Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma-The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010-2016.
Huang L; Zhang X; Wei Z; Xu A
Front Oncol; 2020; 10():539030. PubMed ID: 33585181
[TBL] [Abstract][Full Text] [Related]
24. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
25. Impact of Examined Lymph Node Count for Esophageal Squamous Cell Carcinoma in Patients who Underwent Right Transthoracic Esophagectomy.
Zheng YZ; Li XQ; Wang JY; Yang H; Wen J; Zhai WY; Yuan LX; Fu SS; Liao HY; Fu JH
Ann Surg Oncol; 2021 Jun; 28(6):3025-3033. PubMed ID: 33073346
[TBL] [Abstract][Full Text] [Related]
26. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.
Zhang N; Bai H; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
Ann Transl Med; 2020 Sep; 8(17):1075. PubMed ID: 33145294
[TBL] [Abstract][Full Text] [Related]
27. Examined and Positive Lymph Node Counts Are Associated with Mortality in Prostate Cancer: A Population-Based Analysis.
Kamel MG; Istanbuly S; Abd-Elhay FA; Mohamed MYF; Huu-Hoai L; Sadik M; Dibas M; Huy NT
Urol Int; 2020; 104(9-10):699-709. PubMed ID: 32268338
[TBL] [Abstract][Full Text] [Related]
28. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.
Hua J; Zhang B; Xu J; Liu J; Ni Q; He J; Zheng L; Yu X; Shi S
Eur J Surg Oncol; 2019 Jun; 45(6):1069-1076. PubMed ID: 30685327
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.
Preisser F; Marchioni M; Nazzani S; Bandini M; Tian Z; Pompe RS; Montorsi F; Saad F; Abdollah F; Steuber T; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):399-406. PubMed ID: 29306731
[TBL] [Abstract][Full Text] [Related]
30. Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort.
Kato M; Shiota M; Kimura T; Hanazawa R; Hirakawa A; Takamatsu D; Tashiro K; Matsui Y; Hashine K; Saito R; Yokomizo A; Yamamoto Y; Narita S; Hashimoto K; Matsumoto H; Akamatsu S; Nishiyama N; Eto M; Kitamura H; Tsuzuki T;
Int J Urol; 2024 Jun; 31(6):662-669. PubMed ID: 38424729
[TBL] [Abstract][Full Text] [Related]
31. Impact of Examined Lymph Node Count on Precise Staging and Long-term Survival After Neoadjuvant Therapy for Carcinoma of the Esophagus: A SEER Database Analysis.
Bao T; Bao L; Guo W
Front Surg; 2022; 9():864593. PubMed ID: 35574562
[TBL] [Abstract][Full Text] [Related]
32. Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.
Nassour I; Christie A; Choti MA; Mansour JC; Minter RM; Polanco PM; Augustine MM; Porembka MR; Xie XJ; Wang SC
J Gastrointest Surg; 2018 May; 22(5):792-801. PubMed ID: 29546687
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study.
Liu Y; Yang H; Fu H; Li M; Feng Z; Peng Z; Liang Z; Wang H
Thorac Cancer; 2019 Jul; 10(7):1636-1643. PubMed ID: 31237106
[TBL] [Abstract][Full Text] [Related]
34. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
[TBL] [Abstract][Full Text] [Related]
35. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
36. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI
Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241
[TBL] [Abstract][Full Text] [Related]
37. Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.
Boormans JL; Wildhagen MF; Bangma CH; Verhagen PC; van Leenders GJ
BJU Int; 2008 Dec; 102(11):1589-93. PubMed ID: 18710447
[TBL] [Abstract][Full Text] [Related]
38. Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population.
Sengupta S; Weerakoon M; Sethi K; Ischia J; Webb DR
BJU Int; 2012 Apr; 109 Suppl 3():48-51. PubMed ID: 22458494
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of nodal staging classification and number of examined lymph nodes among patients with ampullary cancer.
Resende V; Endo Y; Munir MM; Khalil M; Rashid Z; Lima HA; Rawicz-Pruszyński K; Khan MMM; Katayama E; Tsilimigras DI; Pawlik TM
J Gastrointest Surg; 2024 Jan; 28(1):33-39. PubMed ID: 38353072
[TBL] [Abstract][Full Text] [Related]
40. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
